Introduction
Conventional laparoscopic surgery (CLS) for rectal cancer leads to improved patient outcomes and significantly decreases surgical trauma, with less pain, improved cosmetic results, shorter hospital stay, and faster recovery time. Several randomized clinical trials have been conducted by experienced laparoscopic surgeons, showing that locoregional recurrence rates and disease-free and overall survival associated with CLS are similar to those of open surgery (1, 2) . However, there is little evidence in the literature regarding the use of laparoscopic surgery, and the application of this surgery remains controversial. Some studies have reported higher rates of conversion relative to open surgery and positive resection margins (3) (4) (5) , which reflect the technical limitations of CLS. Some reports have shown technical difficulties due to the confined space in the pelvis and the limitations of existing laparoscopic instruments, which have a restricted range of movement compared with that of the surgeon's hands (6, 7) . Pelvic lateral lymph node dissection (LLND), which requires precise surgical techniques, is the standard surgical procedure for patients with advanced lower rectal cancer in Japan (8, 9) . Robot-assisted laparoscopic surgery (RALS) is a minimally invasive approach that could potentially overcome some of the limitations of CLS, as a high definition camera system provides a stable threedimensional view with magnified vision. Moreover, the motionscaling feature reduces physiological tremors, and the wrist motion of the instrument provides superior dexterity. These features enable surgeons to perform high quality operations even in the narrow pelvic cavity. Indeed, several studies have demonstrated the safety and feasibility of robotic colorectal surgery (including LLND) in terms of short-term outcomes (10) (11) (12) . However, evidence from clinical trials of robotic surgery for rectal cancer during the introduction period is still limited.
This study aimed to evaluate the safety of robotic surgery for rectal cancer during the introduction period of the robotic rectal surgery using da Vinci surgical system at two institutes. To demonstrate the safety of this procedure, we evaluated the rate of adverse events and the rate of conversion from RALS to open surgery in two different cancer-specialized centers with a high volume of colorectal surgeries.
Methods

Study design
This prospective, multi-center, single-arm, open-label Phase II study was approved by the institutional review board of National Cancer Center . The study protocol was registered at University Hospital Medical Information Network (UMIN) Center (UMIN000013427).
Patients
Fifty patients with pathologically confirmed adenocarcinoma of the rectum and who were scheduled to undergo rectal surgery were candidates for this study. Patients who were clinically diagnosed as Stages I-III on the basis of colonoscopy, CT scan and MRI were considered eligible. After receiving explanations, patients who agreed to participate in this study underwent RALS, and those who declined underwent CLS. Inclusion criteria were as follows: patients with clinically confirmed tumors located in the rectosigmoid area or in the upper or lower rectum; were estimated to obtain complete resection; had no multiple lesions other than carcinoma in situ; had no bowel obstruction; were aged between 20 and 80 years; had a performance status of 0 or 1 (according to the Eastern Cooperative Oncology Group); had a body mass index less than 30 kg/m 2 ; had no prior abdominal operation except appendectomy; and had sufficient organ function. Exclusion criteria included synchronous or metachronous malignancy (within 5 years) other than carcinoma in situ; prior chemotherapy or radiotherapy for any malignancy; pregnant or lactating females; severe mental disease; continuous systemic steroid therapy; history of acute myocardial infarction or angina within 6 months; uncontrolled hypertension; uncontrolled diabetes and severe respiratory disease. When the tumor was located between the inferior margin of the promontorium and the second sacral vertebra, the location was recorded as rectosigmoid. When the tumor was located between the inferior margin of the second sacral vertebra and peritoneal reflection, the location was recorded as upper rectum. When the tumor was located below the peritoneal reflection, the location was recorded as lower rectum. In the end, 50 patients who agreed to participate underwent RALS. Preparation time was calculated as the time from skin incision to the use of the robotic system. Console time was calculated as the time during which the surgeon performed any procedure using the robotic system. Reconstruction time was calculated as the time from finishing robotic procedures to closing the skin incision.
Clinicopathological variables
Surgical procedure
In all cases, RALS was performed using the da Vinci Surgical System S (Intuitive Surgical, Sunnyvale, CA, USA). The setup of the operation room is shown in Fig. 1 . We usually use monopolar scissors, fenestrated bipolar forceps and double fenestrated grasper. The rectum was mobilized to the appropriate level on the anal side of the tumor using the techniques of total mesorectal excision (TME) and tumor-specific mesorectal excision, as previously described (13, 14) . Autonomic nerve preservation was routinely performed for patients without tumors invading nerves (15, 16) . Robot-assisted LLND was performed when patients had tumors located at the lower border distal to the peritoneal reflection, which had invaded beyond the muscularis propria with any clinical nodal status (17) . Intersphincteric resection (ISR) was performed according to the methods described by Schiessel and colleagues (18) . A totally robotic technique was indicated for anterior resection or abdominoperineal resection (APR) cases from medial-to-lateral dissection to mobilize the pelvic floor or divide the distal rectum. A hybrid technique was indicated for ISR cases to mobilize the splenic flexure. Intestinal reconstruction was performed laparoscopically in all cases. The operation was divided into two phases, abdominal and pelvic phases, and performed as follows. In the abdominal phase, medial-to-lateral dissection, ligation of the inferior mesenteric artery and ligation were performed at the root of the inferior mesenteric artery for advanced tumors deeper than T2, as was mobilization of the sigmoid and descending colon. Rectal mobilization down to the pelvic floor was also performed in TME cases. The following procedure differed depending on the surgical method, anterior resection, ISR and APR. In the case of anterior resection, division of the distal rectum was performed using a linear stapler, and the specimen was extracted by minilaparotomy at the site of the umbilical (camera) port; end-to-end anastomosis was performed using standard double stapling. For ISR, transanal intersphincteric dissection was performed, and the specimen was retrieved transanally, followed by colo-anal anastomosis with hand-sewn sutures. For APR, perineal dissection of the pelvic diaphragm was performed, and the specimen was retrieved through the perineal wound, followed by construction of a sigmoid colostomy. After specimen removal, LLND was performed for advanced tumors prior to intestinal reconstruction. Finally, a diverting ileostomy was established if the tumor was located near the anal canal.
Endpoints and patient management
The primary endpoint was the rate of adverse events that occurred intraoperatively as well as postoperatively. The secondary endpoint was the rate of conversion to open surgery or CLS. These endpoints were evaluated to assess the safety of robotic rectal surgery during its introduction period at the study institutes. Since the surgeon in the present study were not accustomed to robotic rectal surgery, to ensure patient safety, conversion criteria to open surgery or CLS were defined as follows: intraoperative bleeding exceeding 700 ml, and operative time exceeding 7.5 h before specimen extraction. All adverse events were reported and classified by investigators according to Common Terminology Criteria for Adverse Events (CTCAE) v4.0. To estimate late postoperative adverse events, patients were followed for at least 3 months postoperatively.
Statistical analysis
Parametric variables are reported as median (range). Statistical analysis was carried out using SPSS for Windows (version 23.0, SPSS Inc., Chicago, IL, USA) software.
Results
From April 2014 through July 2016, 30 patients from the National Cancer Center Hospital and 20 from the National Cancer Center East Hospital were enrolled in this study. A single surgeon performed RALS at each institute. Table 1 shows the characteristics of patients who participated in this study along with tumor data. Among the patients, 10 (20%) had rectosigmoid cancer, 17 (34%) had upper rectal cancer, and 23 (46%) had lower rectal cancer; 25 (50%) had cT1 tumors, 7 (14%) had cT2 tumors, 17 (34%) had cT3 tumors and 1 (2%) had a cT4 tumor. Table 2 shows the details of operations performed, which included six (12%) cases of high anterior resection, 32 (64%) cases of low anterior resection, 11 (22%) cases of ISR, and 1 (2%) case of APR. LLND was performed in 6 (12%) patients for all indicated cases; one case was unilateral, five cases were bilateral. Median operative time was 347 (216-627) min in all patients. Median operative time without LLND was 306 (216-505) min, and that with rectosigmoid cancer was 263 (240-353) min. In addition, that with LLND was 443 (433-627) min. The breakdown of operative time was as follows: median preparation time, 34 (7-62) min; Table 3 . Median number of harvested lymph nodes was 17 (range; 3-60) without LLND, and that with LLND was 22 (14-40). All radial resection margins were negative, and pathologically complete resection was achieved in all cases. Pathological stages based on UICC classification were Stage 0 in 1 (2%), stage I in 28 (56%), Stage II in 7 (14%), Stage III in 14 (28%), and Stage IV in 0 patients.
Regarding time to recovery of bowel function, the median number of days to first flatus was 2 (range; 1-6). More than half of the patients (27 patients, 54%) did not require analgesics during the postoperative course. Median postoperative body temperature was 37.4°C (range; 36.8-38.7) and was the highest on postoperative Day 1, and decreased to 37.3°C (36.4-38.4) and 37.0°C (36.3-38.5) on postoperative Days 2 and 3. Reoperation was performed only in 1 (2%) patient. Median postoperative hospital stay was 9 (range; 7-33) days. There were no recorded mortalities. Table 4 summarizes postoperative complications as assessed by CTCAE v4.0. Eight (16%) patients developed complications, while the remaining 42 (84%) were free of complications. One patient (2%) who developed urinary tract infection recovered fully as regards the urinary symptoms. Two Grade-4 complications were reported. One patient had a chest congestion and hypoxia following the operation, another patient had an anastomotic leakage, which required reoperation in the abdominal cavity.
Discussion
Since the first laparoscopic segmental colectomy was performed in 1991 (19) , minimally invasive surgery has expanded progressively. Due to the limitations including the unstable, two-dimensional view of the operative field and poor ergonomics of surgical tools, laparoscopic surgery for rectal cancer in the narrow pelvic space remains challenging, and it has been difficult to demonstrate its superiority over open surgery in terms of oncological and functional outcomes (3, 20, 21) . RALS, using the da Vinci Surgical System, has technical advantages over CLS, as it provides a stable three-dimensional view and improved dexterity with an increased range of movements at the tips of the Endowrist instruments. These technical advantages might prove useful in the narrow pelvis for maintaining a sufficient surgical dissection plane while avoiding autonomic nerves. The results of this study demonstrated the safety and feasibility of RALS during its introduction period at two institutes.
One concern when using a surgical robot is intraoperative organ damage due to the absence of tactile feedback. In the present study, however, there were no cases of organ damage during the operations. Postoperative complications of RALS was reported 19.5-22.0% of all grades in previous study (12, 22) . With respect to the rate of intraoperative and postoperative adverse events, i.e., the primary endpoint of the present study, the rate of postoperative complications of all grades was 16%, and the rate of severe complications (Grade 3 and greater) was only 4% in this study.
Anastomotic leakage has been reported to occur in 1.8-9.6% in RALS, it is reportedly the most common and important complication, with male sex and degree of anastomosis being significant factors (23) . However, only 2% of patients had anastomotic leakage in this study, despite the fact that 58% of our patients were male, and 46% had tumors below the peritoneal reflection. This study had several advantages that could have contributed to the lower complication rates, including comparatively earlier disease stages, lower BMI and the lack of neoadjuvant chemoradiotherapy. Nonetheless, the low complication rates could also be attributed to features of robotic technology that allow surgeons to perform precise rectal mobilization in keeping the sufficient surgical dissection plane down to the pelvic floor, as well as rectal division and safe reconstruction in the narrow pelvis. CLS has become a popular procedure; however, a recent large randomized controlled trial showed a high rate of conversion to open surgery (9-17%) (1, 3, 21) . Especially, obese patients associate with higher compilation rate and prolonged operation time for open surgery and laparoscopic surgery (24, 25) . We excluded obese patient to guarantee the safety of patients in introduction period, thus we cannot examine the advantage of RALS for these patients in this study. According to a meta-analysis, robot-assisted resection is associated with a significantly lower conversion rate than CLS (OR = 0.26, 95% CI: 0.12-0.57) (23) . Indeed, Sammour et al. report from high-volume centers confirm the low conversion rates (2.2%) associated with robotic surgeries (26) . Consistent with the report, the conversion rate (i.e., the secondary endpoint) was almost same in the present study in spite of initial cases. Other reports from experienced centers, where many robotic surgeries are performed, suggest the presence of a learning curve in reducing conversion rates during robotic surgery (27, 28) . We defined conversion criteria as blood loss and operation time in this study. One patient had intraoperative bleeding and was converted to open surgery. In this patient, bleeding was stopped and the patient recovered postoperatively. When a new technique is introduced, conversion criteria should be defined appropriately to ensure the safety of patients before the plateau of a learning curve is reached.
LLND is the standard procedure in Japan, to control local recurrence of lower rectal cancer. The technique has not gained wide acceptance in western countries, where alternative chemoradiotherapy is popular. The technical advantages of robotic surgery that allow for precise operation may help achieve complete lymphadenectomy with autonomic nerve preservation. Urinary complication was only one case (2.0%) in this study in spite of containing six cases of LLND. This result might reflect the benefit of robotic surgery with precise operation to preserve autonomic nerve to retain voiding function. The results of robotic LLND have only been reported from few institutes, and urinary retention was reported 13.2% with LLND (12, 29) . Given that the present study included only six cases of robotic LLND, further studies with a larger patient population will be needed.
The macroscopic quality of the mesorectal fascia has been suggested to serve as a focal point for quality control of rectal cancer surgery (30) . Recently, two randomized controlled trials proposed the use of novel composite measures as a surrogate for oncologic outcomes (3, 21) . Baik et al. reported improvement in quality of mesorectal specimen by RALS compared with CLS scored by pathologist with no clinical information (p = 0.03) (30) . In Japan, a resected specimen is separated from the intestine and lymph node immediately after operation by surgeons in order to investigate lymph node metastases, and is subsequently examined by pathologists. Thus, a direct comparison of circumferential resection margins between this study and other reports is difficult. In our study, all patients achieved complete resection with negative radial and distal resection margins. Moreover, the number of harvested lymph nodes was greater than that previously reported (1). These results reflect the safety of RALS, although it is noteworthy that our patients had earlier-stage diseases.
This study has several limitations. First, the study was conducted as a single-arm Phase II study to assess the safety and feasibility of RALS, and was not a randomized controlled trial conducted in comparison with CLS. Second, only short-term outcomes were examined. Long-term outcomes and oncologic results should be assessed in the future. Third, voiding and sexual function were not evaluated. A prospective cohort study is currently in progress to evaluate these functions in a comparison of RALS and other modalities.
In conclusion, our results demonstrate the acceptable feasibility and safety of RALS as a valid alternative to CLS. RALS can be performed with low morbidity and low conversion rates for rectal cancer, even during the introduction period.
